PHENOTYPIC CLASSIFICATION OF FONTAN FAILURE: AN INDICATOR OF CLINICAL OUTCOME
Angela Weingarten(Vanderbilt University Medical Center), Larry W. Markham(Riley Hospital for Children), Benjamin P. Frischhertz(Vanderbilt University Medical Center), Ryan Byrne(Monroe Carell Jr. Children's Hospital), Daniel E. Clark(Stanford University), Patricia Y. Chu(Vanderbilt University Medical Center)
Cited by 1
Related Papers
Results of the FUEL Trial
|Circulation|2019|160
Steroid Therapy and Cardiac Function in Duchenne Muscular Dystrophy
|Pediatric Cardiology|2005|125
Abnormalities of Diastolic Function Precede Dilated Cardiomyopathy Associated with Duchenne Muscular Dystrophy
|Journal of the American Society of Echocardiography|2006|89
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation
|Journal of the American College of Cardiology|2023|79
COVID-19 in Adults With Congenital Heart Disease
|Journal of the American College of Cardiology|2021|76